Literature DB >> 17061108

MDMA (Ecstasy) use and psychiatric problems.

Casey R Guillot, Mitchell E Berman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17061108     DOI： 10.1007/s00213-006-0606-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  16 in total

1.  Specific memory deficits in ecstasy users? The results of a meta-analysis.

Authors:  Marinus N Verbaten
Journal:  Hum Psychopharmacol       Date:  2003-06       Impact factor: 1.672

2.  Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.

Authors:  A C Parrott; E Sisk; J J Turner
Journal:  Drug Alcohol Depend       Date:  2000-07-01       Impact factor: 4.492

3.  Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.

Authors:  K Soar; J J D Turner; A C Parrott
Journal:  J Psychopharmacol       Date:  2006-05       Impact factor: 4.153

4.  Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study.

Authors:  Anja C Huizink; Robert F Ferdinand; Jan van der Ende; Frank C Verhulst
Journal:  BMJ       Date:  2006-02-24

Review 5.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

6.  Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

Authors:  Una D McCann; Zsolt Szabo; Esen Seckin; Peter Rosenblatt; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

7.  Psychosocial profiles of older adolescent MDMA users.

Authors:  Lynn T Singer; Teresa J Linares; Shana Ntiri; Racquel Henry; Sonia Minnes
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

8.  Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.

Authors:  Maartje M L de Win; Liesbeth Reneman; Johannes B Reitsma; Gerard J den Heeten; Jan Booij; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

Review 9.  Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.

Authors:  R Thomasius; P Zapletalova; K Petersen; R Buchert; B Andresen; L Wartberg; B Nebeling; A Schmoldt
Journal:  J Psychopharmacol       Date:  2006-03       Impact factor: 4.153

Review 10.  Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review.

Authors:  Alonso G Montoya; Renée Sorrentino; Scott E Lukas; Bruce H Price
Journal:  Harv Rev Psychiatry       Date:  2002 Jul-Aug       Impact factor: 3.732
View more
  2 in total

1.  MDMA administration decreases serotonin but not N-acetylaspartate in the rat brain.

Authors:  Shane A Perrine; Farhad Ghoddoussi; Mark S Michaels; Elisabeth M Hyde; Donald M Kuhn; Matthew P Galloway
Journal:  Neurotoxicology       Date:  2010-08-26       Impact factor: 4.294

2.  MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology.

Authors:  P Sáez-Briones; A Hernández
Journal:  Curr Neuropharmacol       Date:  2013-09       Impact factor: 7.363
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.